Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system.

IMPORTANCE Health care-associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. Better evaluation of the costs of these infections could help providers and payers to justify investing in prevention. OBJECTIVE To estimate costs associated with the most significant and targetable HAIs. DATA SOURCES For estimation of attributable costs, we conducted a systematic review of the literature using PubMed for the years 1986 through April 2013. For HAI incidence estimates, we used the National Healthcare Safety Network of the Centers for Disease Control and Prevention (CDC). STUDY SELECTION Studies performed outside the United States were excluded. Inclusion criteria included a robust method of comparison using a matched control group or an appropriate regression strategy, generalizable populations typical of inpatient wards and critical care units, methodologic consistency with CDC definitions, and soundness of handling economic outcomes. DATA EXTRACTION AND SYNTHESIS Three review cycles were completed, with the final iteration carried out from July 2011 to April 2013. Selected publications underwent a secondary review by the research team. MAIN OUTCOMES AND MEASURES Costs, inflated to 2012 US dollars. RESULTS Using Monte Carlo simulation, we generated point estimates and 95% CIs for attributable costs and length of hospital stay. On a per-case basis, central line-associated bloodstream infections were found to be the most costly HAIs at $45,814 (95% CI, $30,919-$65,245), followed by ventilator-associated pneumonia at $40,144 (95% CI, $36,286-$44,220), surgical site infections at $20,785 (95% CI, $18,902-$22,667), Clostridium difficile infection at $11,285 (95% CI, $9118-$13,574), and catheter-associated urinary tract infections at $896 (95% CI, $603-$1189). The total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line-associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). CONCLUSIONS AND RELEVANCE While quality improvement initiatives have decreased HAI incidence and costs, much more remains to be done. As hospitals realize savings from prevention of these complications under payment reforms, they may be more likely to invest in such strategies.

[1]  Stephen T. Buckland,et al.  Monte Carlo confidence intervals , 1984 .

[2]  T. Brennan,et al.  The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. , 1991, The New England journal of medicine.

[3]  D. Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[4]  D. Sexton,et al.  Nosocomial Methicillin-Resistant and Methicillin-Susceptible Staphylococcus Aureus Primary Bacteremia: At What Costs? , 1999, Infection Control &#x0026; Hospital Epidemiology.

[5]  M. Higgins,et al.  The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. , 1999, American journal of respiratory and critical care medicine.

[6]  Fundamentals of Healthcare Financial Management: A Practical Guide to Fiscal Issues and Activities , 1999 .

[7]  W E Wilkinson,et al.  The Impact of Surgical-Site Infections in the 1990s: Attributable Mortality, Excess Length of Hospitalization, And Extra Costs , 1999, Infection Control &#x0026; Hospital Epidemiology.

[8]  C. Hollenbeak,et al.  The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. , 2000, Chest.

[9]  L. Kohn,et al.  To Err Is Human : Building a Safer Health System , 2007 .

[10]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.

[11]  R Consunji,et al.  Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. , 2001, Archives of surgery.

[12]  Jordi Rello,et al.  Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. , 2002, Chest.

[13]  K. K. Lai,et al.  Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. , 2002, American journal of infection control.

[14]  D. Maki,et al.  The Direct Costs of Nosocomial Catheter-Associated Urinary Tract Infection in the Era of Managed Care , 2002, Infection Control &#x0026; Hospital Epidemiology.

[15]  D. Sexton,et al.  The Impact of Surgical-Site Infections Following Orthopedic Surgery at a Community Hospital and a University Hospital Adverse Quality of Life, Excess Length of Stay, and Extra Cost , 2002, Infection Control &#x0026; Hospital Epidemiology.

[16]  C. Kelly,et al.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  B. Waterman,et al.  Risk Factors for Spinal Surgical-Site Infections in a Community Hospital: A Case–Control Study , 2003, Infection Control &#x0026; Hospital Epidemiology.

[18]  Victoria J. Fraser,et al.  Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center* , 2003, Critical care medicine.

[19]  M. Olsen,et al.  Risk factors for surgical site infection in spinal surgery. , 2003, Journal of neurosurgery.

[20]  John A. Cowan,et al.  Complications and costs after high-risk surgery: where should we focus quality improvement initiatives? , 2003, Journal of the American College of Surgeons.

[21]  I. Toumpoulis,et al.  The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. , 2005, Chest.

[22]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[23]  M. Owings,et al.  Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003 , 2006, Emerging Infectious Diseases.

[24]  C. Hollenbeak,et al.  Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital* , 2006, Critical care medicine.

[25]  Thomas Faunce,et al.  Decision-analytical modelling in health-care economic evaluations , 2008, The European Journal of Health Economics.

[26]  D. Cardo,et al.  Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002 , 2007, Public health reports.

[27]  J Jaime Caro,et al.  The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. , 2007, Infection control and hospital epidemiology.

[28]  M. Rosenthal,et al.  Nonpayment for performance? Medicare's new reimbursement rule. , 2007, The New England journal of medicine.

[29]  D. Rothenberger,et al.  Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. , 2007, Archives of surgery.

[30]  S. Saint,et al.  Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals , 2008, Infection Control &#x0026; Hospital Epidemiology.

[31]  M. Olsen,et al.  Hospital-associated costs due to surgical site infection after breast surgery. , 2008, Archives of surgery.

[32]  J. Rombeau Increasing Prevalence and Severity of Clostridium difficile Colitis in Hospitalized Patients in the United States , 2008 .

[33]  H. Luft,et al.  Medicare's policy not to pay for treating hospital-acquired conditions: the impact. , 2009, Health affairs.

[34]  G. de Lissovoy,et al.  Surgical site infection: incidence and impact on hospital utilization and treatment costs. , 2009, American journal of infection control.

[35]  R. Chinn,et al.  National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. , 2009, American journal of infection control.

[36]  K. Schmader,et al.  The Effect of Surgical Site Infection on Older Operative Patients , 2009, Journal of the American Geriatrics Society.

[37]  R. Scott,et al.  The Direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention , 2009 .

[38]  D. Nicolau,et al.  Deep and organ/space infections in patients undergoing elective colorectal surgery: incidence and impact on hospital length of stay and costs. , 2009, American journal of surgery.

[39]  K. Schmader,et al.  Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study , 2009, PloS one.

[40]  David C. Chan,et al.  Improving safety and eliminating redundant tests: cutting costs in U.S. hospitals. , 2009, Health affairs.

[41]  C. Landrigan,et al.  Temporal trends in rates of patient harm resulting from medical care. , 2010, The New England journal of medicine.

[42]  Lee H. Harrison,et al.  Health care-associated invasive MRSA infections, 2005-2008. , 2010, JAMA.

[43]  B. Hamilton,et al.  Attributable Costs of Surgical Site Infection and Endometritis after Low Transverse Cesarean Delivery , 2010, Infection Control &#x0026; Hospital Epidemiology.

[44]  A. Anzueto,et al.  Economic Burden of Ventilator-Associated Pneumonia Based on Total Resource Utilization , 2008, Infection Control &#x0026; Hospital Epidemiology.

[45]  Hannah R Rothstein,et al.  A basic introduction to fixed‐effect and random‐effects models for meta‐analysis , 2010, Research synthesis methods.

[46]  Margaret A Dudeck,et al.  National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module. , 2011, American journal of infection control.

[47]  Kelly D Peterson,et al.  National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module. , 2011, American journal of infection control.

[48]  Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. , 2011, MMWR. Morbidity and mortality weekly report.

[49]  C. Umscheid,et al.  Estimating the Proportion of Healthcare-Associated Infections That Are Reasonably Preventable and the Related Mortality and Costs , 2011, Infection Control &#x0026; Hospital Epidemiology.

[50]  M. Kollef,et al.  Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort , 2012, Infection Control &#x0026; Hospital Epidemiology.